# Open Label Immunotherapy Trial for Ovarian Cancer

> **NCT03556566** · PHASE2 · UNKNOWN · sponsor: **Immunitor LLC** · enrollment: 20 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** Tableted vaccine (V3-OVA) containing ovarian cancer antigens

## Key facts

- **NCT ID:** NCT03556566
- **Lead sponsor:** Immunitor LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2019-11-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03556566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03556566, "Open Label Immunotherapy Trial for Ovarian Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03556566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*